摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Ethyl 4-[3-cyano-5-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propoxy]indol-1-yl]benzoate | 1071971-16-8

中文名称
——
中文别名
——
英文名称
Ethyl 4-[3-cyano-5-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propoxy]indol-1-yl]benzoate
英文别名
——
Ethyl 4-[3-cyano-5-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propoxy]indol-1-yl]benzoate化学式
CAS
1071971-16-8
化学式
C26H29N3O5
mdl
——
分子量
463.533
InChiKey
WHQTYLQYHGABOQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.6
  • 重原子数:
    34
  • 可旋转键数:
    11
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    103
  • 氢给体数:
    1
  • 氢受体数:
    6

文献信息

  • (AZA)INDOLE DERIVATIVE AND USE THEREOF FOR MEDICAL PURPOSES
    申请人:Shimizu Kazuo
    公开号:US20110230454A1
    公开(公告)日:2011-09-22
    The present invention provides compounds useful as agents for the prevention or treatment of a disease associated with abnormal serum uric acid level which has a uricosuric activity or the like. The present invention relates to (aza)indole derivatives represented by the following general formula (I) having xanthine oxidase inhibitory activities and useful as agents for the prevention or treatment of a disease associated with abnormality of serum uric acid level, prodrugs thereof, or salts thereof. In the formula (I), T represents nitro or cyano and the like; ring J represents aryl or heteroaryl and the like; Q represents carboxy or 5-tetazolyl and the like; Y represents H, OH, NH 2 , halogen, nitro, alkyl, alkoxy and the like; X 1 , X 2 and X 3 independently represent CR 2 or N; R 1 and R 2 independently represent halogen, cyano, haloalkyl, A-D-E-G, —N(-D-E-G) 2 and the like, in the formula, A represents a single bond, O, S and the like; D and G independently represent optionally substituted alkylene, cycloalkylene, heterocycloalkylene, arylene, heteroarylene and the like; E represents a single bond, O, S, COO, SO 2 and the like.
    本发明提供了一种化合物,其具有尿酸排泄活性或类似作用,可用作预防或治疗与异常血清尿酸平相关的疾病的药剂。本发明涉及以下通式(I)所代表的(氮)吲哚生物,其具有黄嘌呤氧化酶抑制活性,并可用作预防或治疗与血清尿酸平异常相关的疾病的药剂,其前体药物或盐。在公式(I)中,T代表硝基或基等;环J代表芳基或杂环芳基等;Q代表羧基或5-四唑基等;Y代表H、OH、NH2、卤素、硝基、烷基、烷氧基等;X1、X2和X3独立地代表CR2或N;R1和R2独立地代表卤素、基、卤代烷基、A-D-E-G、-N(-D-E-G)2等,在公式中,A代表单键,O,S等;D和G独立地代表可选的取代的烷基,环烷基,杂环烷基,芳基,杂环芳基等;E代表单键,O,S,COO,SO2等。
  • US8466152B2
    申请人:——
    公开号:US8466152B2
    公开(公告)日:2013-06-18
  • US8829040B2
    申请人:——
    公开号:US8829040B2
    公开(公告)日:2014-09-09
  • US8993616B2
    申请人:——
    公开号:US8993616B2
    公开(公告)日:2015-03-31
查看更多